DENTSPLY SIRONA Inc. (XRAY) Stock Forecast
XRAY analyst forecast
as of October 18, 2026- Analyst consensus
- Hold 3.29 / 5 from 17 analysts
- Price target
- $12.67 average of analyst targets
- Upside to target
- +47.8% from the latest close
- Next earnings
- November 5, 2026 EPS estimate $0.30
- 52-week range
- $8.44 – $14.68
XRAY analyst ratings
17 analystsNumber of analysts at each rating.
XRAY price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
XRAY earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.31 | $0.26 | $0.34 | $0.37 | −16.3% | 16 |
| Current fiscal year (2026) | $1.49 | $1.28 | $1.61 | $1.60 | −6.6% | 17 |
| Next fiscal year (2027) | $1.50 | $1.36 | $1.65 | $1.49 | +0.1% | 17 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
XRAY revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $863.1M | $850.0M | $874.0M | −4.5% | 14 |
| Current fiscal year (2026) | $3.57B | $3.50B | $3.61B | −2.9% | 16 |
| Next fiscal year (2027) | $3.62B | $3.56B | $3.67B | +1.3% | 15 |
XRAY EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
XRAY revenue: reported and forecast
XRAY EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.37 | $0.32 | $0.31 | $0.31 | $0.31 | −16.7% | 0 up · 1 down |
| Current fiscal year (2026) | $1.42 | $1.50 | $1.50 | $1.49 | $1.49 | +5.2% | 0 up · 3 down |
| Next fiscal year (2027) | $1.55 | $1.52 | $1.52 | $1.50 | $1.50 | −3.6% | 0 up · 4 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
XRAY earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; XRAY beat in 9 of 12.
What analysts expect from XRAY
17 analysts cover DENTSPLY SIRONA; their consensus rating is hold (3.29 on a 1–5 scale, where 5 is a strong buy). The average price target is $12.67, 47.8% above the latest close of $8.57. Analysts expect earnings of $1.49 per share for 2026, −6.6% from a year earlier. For 2027 the average estimate is $1.50 per share on revenue of $3.6 billion. DENTSPLY SIRONA beat the EPS estimate in 9 of the last 12 quarters.
Related: XRAY income statement, XRAY key metrics, XRAY chart. See the XRAY stock overview for the latest quote and news.
XRAY forecast FAQ
What is DENTSPLY SIRONA's price target?
The average analyst price target for DENTSPLY SIRONA is $12.67, 47.8% above the latest close of $8.57.
Is DENTSPLY SIRONA a buy, hold or sell?
Of 17 analysts covering DENTSPLY SIRONA, 2 rate it a strong buy, 2 a buy, 12 a hold, 1 a sell and 0 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is DENTSPLY SIRONA's EPS forecast?
Analysts forecast $1.49 per share for 2026 (range $1.28 to $1.61); for 2027 the estimate is $1.50.
What is DENTSPLY SIRONA's revenue forecast?
The average revenue estimate for 2026 is $3.6 billion, growth of −2.9%; for 2027 it is $3.6 billion.
When does DENTSPLY SIRONA report earnings?
DENTSPLY SIRONA is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes; the EPS estimate is $0.30.
Does DENTSPLY SIRONA usually beat earnings estimates?
DENTSPLY SIRONA reported EPS at or above the analyst estimate in 9 of the last 12 quarters.